Hospital Universitari General De Catalunya

The medical center is at the forefront of breast cancer research, focusing on innovative treatments for ER-positive, HER2-negative and triple-negative breast cancer. The center's studies explore the efficacy of novel drug combinations, aiming to improve progression-free survival rates and manage treatment-related side effects.

• ER-positive, HER2-negative breast cancer
• Triple-negative breast cancer
• Hormone receptor-positive, HER2-low breast cancer

Through these studies, the center contributes significantly to the development of personalized cancer therapies, enhancing patient outcomes and quality of life.

Specializing in Alzheimer's disease research, the center conducts trials on innovative therapies targeting early-stage cognitive decline. These studies aim to slow disease progression and improve cognitive function, utilizing advanced biomarkers and novel therapeutic agents.

• Early Alzheimer's disease
• Preclinical Alzheimer's disease
• Mild cognitive impairment due to Alzheimer's

The center's work in this field is pivotal in advancing our understanding of neurodegenerative diseases and developing effective interventions.

The center is renowned for its research in Parkinson's disease, focusing on the safety and efficacy of new treatments aimed at reducing motor fluctuations and improving patient quality of life. These studies explore both early-stage interventions and long-term management strategies.

• Early Parkinson's disease
• Idiopathic Parkinson's disease

By advancing therapeutic options, the center plays a crucial role in enhancing the lives of those affected by Parkinson's disease.

Focusing on age-related macular degeneration and diabetic retinopathy, the center's research aims to develop treatments that preserve vision and improve patient outcomes. These studies evaluate the efficacy of novel drug formulations and delivery systems.

• Neovascular age-related macular degeneration
• Diabetic retinopathy

The center's contributions are vital in the quest to combat vision loss and enhance the quality of life for patients with these conditions.

In the realm of infertility treatment, the center is pioneering research on innovative hormonal therapies and their impact on reproductive outcomes. These studies aim to optimize treatment protocols and improve success rates for patients undergoing assisted reproductive technologies.

• Infertility treatments
• Oocyte maturation

Through its research, the center is enhancing the understanding and management of reproductive health challenges.